Magnetic resonance imaging

Circle Cardiovascular Imaging Announces Partnership with DiA Imaging Analysis to Deliver All-in-One Comprehensive AI-Based Cardiovascular Imaging Solutions

Monday, June 14, 2021 - 1:59pm

This collaboration will deliver expanded state-of-the-art multi-modality imaging solutions to Circle CVI's customers, while providing new opportunities for physicians, patients, and hospitals worldwide.

Key Points: 
  • This collaboration will deliver expanded state-of-the-art multi-modality imaging solutions to Circle CVI's customers, while providing new opportunities for physicians, patients, and hospitals worldwide.
  • "By adding DiA's solutions, Circle CVI is broadening its extensive portfolio of cardiovascular MR and CT, to include ultrasound imaging functionality, offerings that are unparalleled in the market," said Greg Ogrodnick, CEO of Circle Cardiovascular Imaging.
  • About Circle Cardiovascular Imaging Inc.
    Circle Cardiovascular Imaging Inc. develops world-class, advanced reading and reporting solutions for cardiac imaging.
  • Circle CVI's imaging platform, cvi42, is the best-in-class cardiovascular imaging reading and reporting solution for cardiac MR, cardiac CT, cardiac interventional planning and electrophysiology.

Introducing Our FDA Designated Breakthrough: BrainSee Enterprise Software for Prognostic Measurement after aMCI Diagnosis

Thursday, June 10, 2021 - 11:41pm

Darmiyan is pleased to announce that the company's first product BrainSee has obtained from the FDA a breakthrough designation granted for innovative medical devices.

Key Points: 
  • Darmiyan is pleased to announce that the company's first product BrainSee has obtained from the FDA a breakthrough designation granted for innovative medical devices.
  • Through the breakthrough program FDA separately discerned BrainSee offers a distinct advantage over existing interventions in addressing and assessing debilitating or life-threatening diseases.
  • Darmiyan's BrainSee enterprise software offers a prognostic measurement re: Alzheimer's disease based on brain MRI and cognitive assessments after an aMCI diagnosis, which may be especially useful as you consider the opportunity offered by the newly approved Aduhelm.
  • Darmiyan's proprietary technology using brain MRI is patented in the US; patents are pending in Europe, Japan and China.

Canon Medical’s Digital PET/CT System Receives FDA Clearance for AI-Based Image Reconstruction Technology

Thursday, June 10, 2021 - 1:00pm

An innovative approach to reconstruction, AiCE on the Cartesion Prime Digital PET/CT can provide fast exams at a lower dose with better image quality than traditionally acquired during both the PET and CT acquisitions.

Key Points: 
  • An innovative approach to reconstruction, AiCE on the Cartesion Prime Digital PET/CT can provide fast exams at a lower dose with better image quality than traditionally acquired during both the PET and CT acquisitions.
  • Were taking innovation in molecular imaging one step further than ever thought possible with the availability of DLR on a digital PET/CT system.
  • About Canon Medical Systems USA, Inc.
    Canon Medical Systems USA, Inc., headquartered in Tustin, Calif., markets, sells, distributes and services radiology and cardiovascular systems, including CT, MR, ultrasound, X-ray and interventional X-ray equipment.
  • At Canon Medical, we work hand in hand with our partners - our medical, academic and research community.

Magnetic Resonance Imaging (MRI) Provides Certain Advantages Compared to Computed Tomography (CT) Technology

Tuesday, June 8, 2021 - 4:12pm

SARASOTA, Fla., June 8, 2021 /PRNewswire/ -- Peter Solodko, CEO of A1 Medical Imaging with Open MRI centers in Florida and Georgia, explains the advantages of magnetic resonance imaging (MRI) compared to computed tomography (CT) when it comes to obtaining detailed images of the inside of the human body.

Key Points: 
  • SARASOTA, Fla., June 8, 2021 /PRNewswire/ -- Peter Solodko, CEO of A1 Medical Imaging with Open MRI centers in Florida and Georgia, explains the advantages of magnetic resonance imaging (MRI) compared to computed tomography (CT) when it comes to obtaining detailed images of the inside of the human body.
  • "Computerized tomography uses computers and rotating X-ray emissions to create cross-sectional images of the internal anatomy," Solodko said.
  • "Magnetic resonance imaging is a non-invasive technology that uses magnets, radio waves, and computers to obtain more detailed pictures of a patient's anatomy than CT," Peter Solodko stated.
  • "All of our A1 Medical Imaging centers utilize an open MRI design to reduce the sense of confinement and claustrophobia."

Hyperfine Names Veteran Medical Device and Innovation Leader Dave Scott President and CEO

Tuesday, June 8, 2021 - 3:00pm

Hyperfine, Inc., creators of the worlds first portable compact magnetic resonance imaging device, has named medical device industry veteran Dave Scott as its President & Chief Executive Officer to support the companys commercialization and growth strategy.

Key Points: 
  • Hyperfine, Inc., creators of the worlds first portable compact magnetic resonance imaging device, has named medical device industry veteran Dave Scott as its President & Chief Executive Officer to support the companys commercialization and growth strategy.
  • View the full release here: https://www.businesswire.com/news/home/20210608005159/en/
    Dave Scott, President and CEO of Hyperfine, Inc. (Photo: Business Wire)
    Mr. Scott joins Hyperfine with a 25-year career building and leading high-performing teams at both startups and Fortune 500 companies related to digital surgery, digital health ecosystems, surgical robotics, and medical imaging and diagnostics.
  • As CEO, Scott will lead the companys bold strategic growth plans for the rapid commercialization and adoption of the category-defining Swoop MR Imaging System.
  • Before joining Hyperfine as CEO, Mr. Scott led advanced R&D innovation teams within Apples confidential Special Projects Group.

ClearPoint Neuro, Inc. Congratulates BlueRock Therapeutics on First Patient Dosed with DA01 in Phase 1 Study in Patients with Advanced Parkinson’s Disease

Tuesday, June 8, 2021 - 12:30pm

The clinical trial, designed to evaluate the safety, tolerability, and preliminary efficacy of DA01 in patients with PD, is expected to enroll ten patients at sites in the United States and Canada.

Key Points: 
  • The clinical trial, designed to evaluate the safety, tolerability, and preliminary efficacy of DA01 in patients with PD, is expected to enroll ten patients at sites in the United States and Canada.
  • Dr. Tabar utilized the ClearPoint Neuro Navigation System with two SmartFrames, and six SmartFlow cannulae to surgically transplant dopamine-producing cells into the putamen under live-MRI guidance.
  • The Companys clinical specialist team provided support during the dose administration and assisted the study team to execute the MRI workflow which ClearPoint helped design for the clinical trial protocol.
  • Parkinsons disease is a progressive neurodegenerative disorder caused by nerve cell damage in the brain, leading to decreased dopamine levels.

GBT Seeking to Adapt xCalibre Pattern Recognition Technology for Medical Imaging Analytics

Tuesday, June 8, 2021 - 11:00am

xCalibre imaging algorithms has the capability of processing high resolution images and videos detecting wide variety of pre-defined irregular objects.

Key Points: 
  • xCalibre imaging algorithms has the capability of processing high resolution images and videos detecting wide variety of pre-defined irregular objects.
  • Using GBTs proprietary neural network technology along with its computational geometry algorithms, GBT is seeking to adapt xCalibre to analyze post processed imaging of CT, Ultrasound, MRI and X-RAY.
  • xCalibre system makes it possible to process and analyze imaging information, identifying anomalies of interest.
  • We believe our AI technology could make it a potential intelligent assistant for medical professionals in wide variety of health fields.

Global Medical Imaging Market Report 2021-2026: Analysis by X-Ray, Ultrasound, MRI, CT Scan, Nuclear Imaging - ResearchAndMarkets.com

Tuesday, June 8, 2021 - 10:27am

The "Global Medical Imaging Market (2021 Edition) - Analysis By Product (X-Ray, Ultrasound, MRI, CT Scan, Nuclear Imaging), End-User, Application, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Medical Imaging Market (2021 Edition) - Analysis By Product (X-Ray, Ultrasound, MRI, CT Scan, Nuclear Imaging), End-User, Application, By Region, By Country: Market Insights and Forecast with Impact of Covid-19 (2021-2026)" report has been added to ResearchAndMarkets.com's offering.
  • Global Medical Imaging Market was valued at USD 39.94 Billion in the year 2020.
  • Medical Imaging refers to use of different imaging modalities to get visual representations of interior of a body for diagnostic and therapeutic purposes.
  • The medical imaging field has advanced at a great pace, with technological advancements playing a pivotal role in the growth of the market.

Tower Radiology Expands 3D Mammography to West Pasco County

Monday, June 7, 2021 - 4:00pm

TAMPA, Fla., June 7, 2021 /PRNewswire-PRWeb/ -- Tower Radiology has expanded 3D mammography (Tomosynthesis) into West Pasco County with its addition at our New Port Richey location at 5539 Marine Pkwy., New Port Richey, FL 34652.

Key Points: 
  • TAMPA, Fla., June 7, 2021 /PRNewswire-PRWeb/ -- Tower Radiology has expanded 3D mammography (Tomosynthesis) into West Pasco County with its addition at our New Port Richey location at 5539 Marine Pkwy., New Port Richey, FL 34652.
  • Patients who benefit most from 3D mammography are those who have dense breasts, but women with non-dense breasts can also benefit in the same ways.
  • Established in 1992, Tower Radiology provides quality radiology services in a comfortable, convenient, outpatient setting throughout Hillsborough, Pasco and East Pinellas Counties.
  • Accredited by the American College of Radiology, Tower offers specialized services such as 3D mammography, high field wide-bore MRI, weight-bearing open MRI, extremity open MRI, cardiac MRI, CT low-dose lung screening and PET/CT.

GE Healthcare and the American College of Cardiology Join Forces to Advance AI in Cardiac Care

Thursday, June 3, 2021 - 2:00pm

GE Healthcare will lend its unique perspective as a leading global medical technology and digital solutions innovator in connected cardiovascular care to this forum.

Key Points: 
  • GE Healthcare will lend its unique perspective as a leading global medical technology and digital solutions innovator in connected cardiovascular care to this forum.
  • We are excited to have GE Healthcare join forces with the Applied Health Innovation Consortium, says John Rumsfeld, MD, PhD, FACC, ACC Chief Innovation Officer and Chief Science & Quality Officer.
  • In our mission to transform cardiovascular care and improve heart health, GE Healthcare is a great collaborator to help build a roadmap for AI and digital technology that bridges gaps in clinical care.
  • GE Healthcare is the $18 billion healthcare business of GE (NYSE: GE).